Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
P114058-10mg | 10mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $187.90 | |
P114058-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $842.90 |
Selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor
Synonyms | Picropodophyllin|Picropodophyllotoxin|477-47-4|AXL1717|Picropodophyllin (PPP)|IGF-1R Inhibitor, PPP|AXL-1717|AXL 1717|NSC36407|NSC-36407|17434-18-3|Podophyllotoxin picropodophyllin|(-)PPP|(5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetr |
---|---|
Specifications & Purity | analytical standard,≥98% |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Grade | analytical standard, Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Insulin-like growth factor I receptor inhibitor |
Product Description | Picropodophyllotoxin is an insulin-like growth factor-I (IGF-I) receptor kinase inhibitor. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one |
---|---|
INCHI | InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19+,20-/m0/s1 |
InChi Key | YJGVMLPVUAXIQN-HAEOHBJNSA-N |
Canonical SMILES | COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O |
Isomeric SMILES | COC1=CC(=CC(=C1OC)OC)[C@H]2[C@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O |
WGK Germany | 3 |
RTECS | LV2510000 |
PubChem CID | 72435 |
UN Number | 3462 |
Molecular Weight | 414.41 |
PubChem CID | 72435 |
---|---|
CAS Registry No. | 477-47-4 |
ChEMBL Ligand | CHEMBL283120 |
DrugBank Ligand | DB01179 |
Enter Lot Number to search for COA:
Pictogram(s) | GHS06 |
---|---|
Signal | Danger |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H301:Toxic if swallowed H312:Harmful in contact with skin |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P301+P310:IF SWALLOWED: Immediately call a POISON CENTER/doctor/... |
WGK Germany | 3 |
RTECS | LV2510000 |
1. Linder S, Shoshan MC, Gupta RS. (2007) Picropodophyllotoxin or podophyllotoxin does not induce cell death via insulin-like growth factor-I receptor.. Cancer Res, 67 (6): (2899; author reply 2899-900). [PMID:17363615] |
2. Girnita A, Girnita L, del Prete F, Bartolazzi A, Larsson O, Axelson M. (2004) Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.. Cancer Res, 64 (1): (236-42). [PMID:14729630] |
3. Ekman S, Frödin JE, Harmenberg J, Bergman A, Hedlund A, Dahg P, Alvfors C, Ståhl B, Bergström S, Bergqvist M. (2011) Clinical Phase I study with an Insulin-like Growth Factor-1 receptor inhibitor: experiences in patients with squamous non-small cell lung carcinoma.. Acta Oncol, 50 (3): (441-7). [PMID:20698809] |
4. Dean M & Rose J. (2018) Activation of the IGF1 receptor stimulates glycogen synthesis by mink uterine epithelial cells.. Mol Reprod Dev, 85 (5): (449-458). [PMID:29573521] |